Tata Elxsi margins miss as Transportation recovery remains uneven

Investment View and Recommendation

Motilal Oswal Financial Services retains its Sell rating on Tata Elxsi after 1QFY27 revenue was broadly in line with expectations, while profitability fell materially short. The broker's central concern is that the growth recovery remains narrow, with the largest Transportation vertical, estimated at about 55% of revenue, yet to recover meaningfully.

Motilal Oswal believes the prevailing valuation already discounts a stronger and broader recovery, leaving limited room for disappointment. The broker has revised its target price to Rs 3,100, valuing Tata Elxsi at 21 times FY28E EPS, compared with the earlier 22 times.

1QFY27 Operating Performance

Tata Elxsi reported 1QFY27 revenue of US$108 million, up 1.3% quarter on quarter in constant currency, broadly matching Motilal Oswal's 1.2% estimate. In rupee terms, revenue, EBIT and adjusted PAT increased 14.5%, 19.2% and 18.2% year on year, respectively.

Growth was led by Media and Communications, which rose 2.9% quarter on quarter in constant currency, and Others, which increased 21%. Healthcare and Life Sciences declined 0.3%, while Transportation declined 0.4%. Geographically, the Americas rose 8.6% quarter on quarter in US-dollar terms, whereas Europe, India and Rest of World declined 3.1%, 3.4% and 13.5%, respectively.

Net headcount fell by 204 sequentially to 11,336, while trailing-12-month attrition increased 20 basis points quarter on quarter to 16%.

Management Commentary and Growth Drivers

Management cited a difficult global environment, including softness in Germany and Continental Europe affecting automotive spending and H-1B-related cost pressure in the US. Transportation and Media and Communications benefited from the ramp-up of large deals, while Healthcare demand remained muted and key-client deal closures were delayed.

Media and Telecom consolidation deals continued to ramp up, with Tata Elxsi benefiting as an incumbent vendor in client mergers and acquisitions. The company retained its FY27 high-single-digit growth aspiration, conditional on a recovery in Healthcare.

Tata Elxsi's Neuron platform helped European telecom client Sky move towards zero-touch network operations, with reported efficiency gains of 30% to 70% across parameters.

Margin Pressure and Delivery Model

Management attributed the margin pressure to approximately 150 basis points of one-off and transition-related costs, including large-deal transitions, employee retention, a customer-specific Chapter 11 provision and upfront annual costs.

A further 220–230 basis points reflected strategic costs related to onsite delivery ramp-up, subcontractors due to US visa constraints, and specialised talent and AI infrastructure. Management expects most one-off costs to unwind over the next one to two quarters, while investment costs should normalise gradually as ramp-ups stabilise and work moves offshore.

However, a company-wide wage hike planned for 2QFY27 is expected to partly offset the margin recovery. Utilisation was about 75%, and management maintained a structural offshore-heavy delivery target of approximately 90:10, despite a temporary 74:26 onsite-offshore mix.

Estimates, Valuation and Outlook

Motilal Oswal cut FY27E and FY28E EPS by approximately 5% and 1%, respectively, because of the 1QFY27 margin miss and slower Transportation recovery. The broker forecasts a US-dollar revenue CAGR of about 5.5% over FY26–FY28, with FY27E and FY28E EBIT margins of 21.6% and 22.5%.

The revised valuation is based on 21 times FY28E EPS, reduced from 22 times, resulting in a target price of Rs 3,100. The broker's cautious view reflects the assessment that the current valuation already assumes a stronger and broader recovery than is currently evident.

Key Risks to the Thesis

• Continued weakness in automotive demand and the European operating environment.
• Muted Healthcare demand and slower recovery in the Healthcare vertical.
• Wage increases and ongoing investment costs weighing on margins.
• Visa-related onsite and subcontractor expenses in the US.
• A slower-than-expected margin recovery as deal ramp-ups and delivery transitions stabilise.

A more constructive view would require broader vertical growth, particularly a sustained recovery in Transportation and Healthcare, alongside stronger margins.